Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer.
Gynecol Oncol
; 167(3): 444-451, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36244826
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Braquiterapia
/
Neoplasias Endometriales
/
Carcinoma Endometrioide
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Gynecol Oncol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos